Matthew Plavan
2019 - Arcadia Biosciences
In 2019, Matthew Plavan earned a total compensation of $581.1K as President and Chief Executive Officer at Arcadia Biosciences, which was about the same as previous year.
Compensation breakdown
Non-Equity Incentive Plan | $154,500 |
---|---|
Option Awards | $105,040 |
Salary | $321,538 |
Total | $581,078 |
Plavan received $321.5K in salary, accounting for 55% of the total pay in 2019.
Plavan also received $154.5K in non-equity incentive plan and $105K in option awards.
Rankings
In 2019, Matthew Plavan's compensation ranked 11,302nd out of 13,971 executives tracked by ExecPay. In other words, Plavan earned more than 19.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,302 | 19th |
Agriculture, Forestry, And Fishing | 36 | 25th |
Agricultural Production Crops | 20 | 33rd |
Plavan's colleagues
We found four more compensation records of executives who worked with Matthew Plavan at Arcadia Biosciences in 2019.
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019